1 9th Annual Training and Educational Symposium September 6, 2012 The Changing Face of Opioid Addiction: A Review of the Research and Considerations for Care Mark Stanford, Ph.D. Santa Clara County Dept of Alcohol & Drug Services Addiction Medicine Division
2 In the last 10 years, the number of people addicted to prescription opioids has increased tremendously. Although heroin use has been the central target for opioid addiction treatment, the emerging use of nonprescribed prescription opioids has changed the picture of opioid use in the United States. Zacny et al. 2003; Fischer et al. 2007; SAMHSA
3 Prescription Drug Abuse In 2010, approximately 7.0 million persons were current users of psychotherapeutic drugs taken nonmedically (2.7 percent of the U.S. population), an estimate similar to that in This class of drugs is broadly described as those targeting the central nervous system, including drugs used to treat psychiatric disorders (NSDUH, 2010). Medications most commonly abused are: Pain relievers million Tranquilizers million Stimulants million Sedatives million
4 Prescription opioids are now more likely to cause or contribute to overdose deaths than heroin or cocaine.
5 Opioid Use in Santa Clara County: Admissions to MMT Type of Opioid Use (N = 1,314) Heroin Pain pills Non Opioid* Heroin Pain pills Non Opioid*
6 Primary, Secondary and Tertiary Drug Use Heroin and Pain Pills Primary Secondary Tertiary None Opioid Use in Santa Clara County: Admissions to MMT Heroin Alcohol Barbiturates Other Sedatives or Hypnotics Methamphetamine Other Amphetamines Other Stimulants Cocaine / Crack Marijuana / Hashish PCP Other Hallucinogens Tranquilizers (Benzodiazepine) Other Tranquilizers Non-Prescription Methadone Oxycodone / OxyContin Other Opiates Over-the-Counter Other Total
7 Opioid Use in Santa Clara County: Admissions to MMT Heroin-only vs other opioid admissions 80% 93% 2006: n = : n = %
8 Opioid Use in Santa Clara County: Admissions to MMT Age at admission 2006: n = : n = 646
9 Opioid Use in Santa Clara County: Admissions to MMT Gender at admission 2006: n = : n = 646
10 Most of the clinical information about prognosis and treatment of opioid addiction is gleaned from studies with heroin addicts. As prescription opioids outpace heroin in many parts of the country, scientists have wondered if there are significant differences between these populations. Biologically, addiction to heroin or prescription opioids would appear to be the same disease, because both types of drugs are opioids, and opioids affect the body the same way.
11 But do all opioid addicts respond to treatment in the same way? Does the old data fit the new patients?
12 Shifting patterns of opioid use has been associated with different psychiatric and drug use patterns among users of heroin compared with users of other opioids and have important implications for treatment and program protocols. Fischer, et al
13 What are these differences? One study with 75 MMT patients found a more severe pattern of drug use and lower social stability among primary heroin users compared with primary users of other opioids and concluded that the 2 groups have distinct treatment responses (Sigmon. 2006). In another study of 178 MMT patients, those using heroin and other opioids were more likely than the users of heroin alone to report problems with alcohol and pain, have more psychiatric problems, and have a low rate of remaining in treatment (Brands, et al. 2004).
14 What are these differences? A 2007 study examined 200 opioid dependent patients who enrolled in a study for buprenorphine treatment. Compared with users of heroin only, users of other opioids only were more likely to be white, had a higher income, had fewer drug treatment episodes, but remained in treatment longer (Moore, et al. 2007). Data analysis from a 2007 survey of 5,663 opioid dependent patients in 72 MMT programs, use of other opioids was associated with being white, young (18 29 years of age), not injecting drugs or having prior methadone treatment, and having chronic pain (Rosenblum, et al. 2007).
15 The NESARC Study A 2011 study used data analysis from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) (N = 43,093) and identified 4 groups from the 9,140 illicit or non-prescribed drug users: 1. Heroin-other opioid users 2. Heroin-only opioid users 3. Other opioid-only users 4. Non-opioid drug users The study then compared demographic and clinical profiles, examined psychiatric disorders and finally, looked at indicators of quality of life according to type of opioid used. Wu LT, Woody G, Yang C, Blazer D. J Addict Med 2011;5: 28-35
16 The NESARC Study The 43,093 respondents in the NESARC study were reflective of national estimates of demographic subgroups and 18,518 were male and 24,575 were female. Substance use and psychiatric disorders were assessed with the Alcohol Use Disorders and Associated Disabilities Interview Schedule DSM IV. It assesses the problems and disorders related to substance abuse, mood, anxiety, and personality.
17 Highlights of the NESARC Study: Characteristics of Opioid Users This study using data from the largest national study of psychiatric disorders to date suggests that opioid users can be categorized into 3 groups based on heroin use status and that these 3 groups have different clinical features. Heroin-other opioid users comprise the most severe subset, whereas other opioid-only users abuse more prescription drugs than heroin-only users. Other opioid-only users also differ from heroin-only users in age (younger) and race/ethnicity (primarily white).
18 Highlights of the NESARC Study Heroin-other opioid users and heroin-only users were more likely than other groups to be older (>45 years), black, have a history of substance abuse treatment, and use other drugs. Heroin-other opioid users and other opioid-only users were more likely than non-opioid users to be male, lack a high school education, and have low family income (< 35,000). Heroin other-opioid users had the highest proportions of use of other drugs. Other opioid-only users had a lower prevalence use of other drugs than heroin-only users except for tranquilizers and sedatives.
19 Highlights of the NESARC Study Heroin-other opioid users and heroin-only users were more likely than other groups to be older (>45 years), black, have a history of substance abuse treatment, and use other drugs. Heroin-other opioid users and other opioid-only users were more likely than non-opioid users to be male, lack a high school education, and have low family income (< 35,000). Heroin other-opioid users had the highest proportions of use of other drugs. Other opioid-only users had a lower prevalence use of other drugs than heroin-only users except for tranquilizers and sedatives.
20 Highlights of the NESARC Study The 4 groups differ from each other in key socioeconomic characteristics, types of other substances used, and history of substance abuse treatment; and all opioid use groups exhibited more pervasive use of substances than non-opioid drug users. Heroin other-opioid users had higher odds of various SUDs than the other opioid-using groups. Other opioid-only users had higher rates of prescription SUDs (sedatives) than heroin-only users. Non-opioid drug users had lower rates of several SUDs than all the opioid using groups and lower rates of mental disorders (mood, anxiety, pathologic gambling, and personality) than other opioid-only users.
21 Highlights of the NESARC Study The most salient findings concern patterns of psychiatric profiles as a function of opioid use status, where heroin-other opioid users displayed the most severe pattern of psychopathology. The majority of individuals in this group not only had an opioid use disorders or other SUDs, but also met criteria for several other mental disorders (mood, 57%; anxiety, 39%; and personality, 48%). This profile of comorbidity suggests that these individuals are likely to be in particular need of psychiatric and substance abuse treatment services (Strain and Stitzer, 2006; Cicero, et al., 2008).
22 Highlights of the NESARC Study Despite the high rate of psychiatric disorders among other opioid-only users, they have a low likelihood of using substance abuse treatment.
23 Considerations as a result of the research At the State Level: Revise CCR Title 9 The State NTP regulations were developed largely for a heroin only user group and need to be revised to account for other opioid using populations. These outdated regs can be a disincentive for other opioid addicted persons from seeking treatment. At the Program Level: Use a good multidimensional assessment instrument to determining where to initiate treatment based on prioritized needs (ASAM, ASI). Clinical ability to provide for the dually diagnosed patient. NTPs should be dual diagnosis capable and clinicians should be dual diagnosis proficient.
24 Considerations For treatment naïve other opioid-only user groups, consider shorter and more frequent counseling sessions (i.e. 20 minutes) than the traditional minute sessions Develop an orientation to treatment group to provide an intro and overview of NTPs, explain methadone as a medication and answer questions a new patient may have. Groups can be cofacilitated by staff and a step-level patient. Consider cofacilitating this group as a requirement for gaining steps 4,5 and 6. Make greater use of the peer facilitated medication-assisted recovery support (MARS) to help patients engage in the treatment process.
25 Considerations Consider an expanded formulary of other medications for opioid addiction including buprenorphine and naltrexone. Offer a variety of group topics that targeting the needs and interests of a diverse opioid using patient population. Use NiaTx or a similar PDSA rapid response quality improvement measure to frequently monitor how well the program is serving patients treatment needs. Use a Client Evaluation of Self and Treatment (CEST) or similar patient feedback tool to determine effectiveness of counseling approaches and how meaningful they are (or are not).
26 Conclusions Overall, heroin users differ from persons using other opioids in demographics, drug use, self-rated health, and psychiatric problems. The diversity in psychopathology supports the need to distinguish heroin-users from other opioid users in clinical settings to better characterize prognosis, and hopefully, optimize treatment response (Brands et al., 2004; Moore et al.,2007.). The research findings underscore the need for continued monitoring of trends in opioid use, distinguishing heroin users from other opioid users in treatment, and developing tailored prevention and treatment programs in response to changing profiles within the opioid-using population (Wu LT, et al., 2011).
Treatment Episode Data Set The TEDS Report July 15, 010 Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 008 In Brief The proportion of all substance abuse treatment admissions
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,
Behavioral Health Barometer United States, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner NASADAD 2015 Annual Meeting Background Goal of Health Care Reform Triple Aim: Better Population
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer
Substance Abuse Treatment Statistics Residents Focus on 2007 to 2011 July 25, 2013 Intentionally blank Department of Human Services Tables of Contents Summary 1 Table 1: Substance Abuse Treatment Enrollments,
Behavioral Health Barometer United States, 2013 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
Behavioral Health Barometer Oklahoma, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No. 283
Behavioral Health Barometer Mississippi, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
Rationale for and approach to treating Opiate Use Disorders Gavin Bart, MD PhD FACP DFASAM Director, Division of Addiction Medicine Department of Medicine Hennepin County Medical Center Associate Professor
Prescription for Danger A Report on the Troubling Trend of Prescription and Over-the-Counter Drug Abuse Among the Nation s Teens OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT
Behavioral Health Barometer United States, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
Behavioral Health Barometer Virginia, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No. 283
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center 1 in 4 Americans will have an alcohol or drug problems at some point in their lives. The number of alcohol abusers and addicts
CHAPTER 6: Substance Abuse and Mental Health A Comparison of Coal Mining Areas to Areas within the Region 6.1 Introduction A key geographic and economic feature of the region is that a large proportion
Substance Abuse 214-215 Chapter 1: Substance Abuse 265 214-215 Health of Boston Substance Abuse Substance abuse involves the excessive use of alcohol or illicit substances (e.g., marijuana, cocaine, heroin,
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
Treatment Episode Data Set (TEDS) Highlights - 2007 National Admissions to Substance Abuse Treatment Services DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration
Treatment Episode Data Set The TEDS Report June 2, 2011 Substance Abuse Treatment Admissions for Abuse of Benzodiazepines Benzodiazepines are a class of central nervous system depressant drugs that are
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
TEENS AND PRESCRIPTION DRUGS An Analysis of Recent Trends on the Emerging Drug Threat OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT FEBRUARY 2007 TABLE OF CONTENTS Introduction
FALL 2015 VOLUME #01 IN G E N UI TY HE A LTH : PRESCRIPTION DRUG REPORT A Review of Medication Monitoring Results of People in Treatment for Serious Mental Illness Knowing the Facts About Medication Adherence
YOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT Siobhan A. Morse, MHSA, CRC, CAI, MAC Director of Fidelity and Research Foundations Recovery Network YOUNG
Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing
Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Audio will begin at 2:00 PM ET. You can listen through your computer
SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services Administration 1 Overview National
Drug Abuse Trends Minneapolis/St. Paul, Minnesota January 21 Carol Falkowski Alcohol and Drug Abuse Division Minnesota Department of Human Services Background This report is produced twice annually for
Addiction Psychiatry Fellowship Rotation Goals & Objectives Table of Contents University Neuropsychiatric Institute (UNI) Training Site 2 Inpatient addiction psychiatry rotation.....2 Outpatient addiction
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
Minnesota Adults with Co-Occurring Substance Use and Mental Health Disorders By Eunkyung Park, Ph.D. Performance Measurement and Quality Improvement May 2006 In Brief Approximately 16% of Minnesota adults
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
Falling in Line with the HIV Cascade of Care Model: A Comparison of HIV and Substance Abuse Outcomes for Treatment Seeking and Non-Treatment Seeking Individuals Living with HIV and Opioid Use Disorders
UTAH Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males and
2013 Annual Conference for Behavioral Health Wichita, Kansas September 18, 2013 Alex Barajas-Muñoz, MS Buprenorphine for Opioid Dependence: A Training for Multidisciplinary Addiction Professionals NIDA/SAMHSA
Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E NDIC and Stockbyte Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type
Adult Summer 8 The chart below summarizes the severity and trends for indicators of drug use and abuse in Broward County, Florida. The Severity Index is based on the number of drug-related deaths, emergency
2012 The State of Prescription Drug Use in Georgia: A Needs Assessment Submitted By: Dr. Sheryl Strasser, Evaluator and Megan Smith, MPH, Assistant Evaluator Georgia State University, Institute of Public
MICHIGAN Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
Screening Patients for Substance Use in Your Practice Setting Learning Objectives By the end of this session, participants will Understand the rationale for universal screening. Identify potential health
National Adolescent Health Information Center N 2007 Fact A H I C Sheet on Substance : Adolescents & Young Adults Highlights: 4 After an increase in the early 1990s, adolescent substance use has decreased
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
Colorado Substance Abuse Treatment Clients with Co-Occurring Disorders, FY05 Introduction Many clients who have chronic substance use disorders often simultaneously suffer from a serious mental disorder.
Recovery Outcomes for Opiate Users FRN Research Report November 2013 Introduction Opiate use in America is at epidemic levels. The latest surveys show 4.5 million Americans using prescription painkillers
Drug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 24 Alice A. Gleghorn, Ph.D. ABSTRACT In San Francisco, increases in heroin consequence indicators (treatment admissions and Drug
Identifying High and Low Risk Practice Areas and Drugs of Choice of Chemically Dependent Nurses Jessica Furstenberg, Kawa Cheong, Ashley Brill, Angela M. McNelis, PhD, RN, Sara Horton-Deutsch, PhD, RN,
Georgia Journal of Public Policy Volume 1 Issue 1 Article 5 3-1-2011 The Burruss Institute of Public Service and Research Kennesaw State University, email@example.com Follow this and additional works
Patterns of Heroin and Other Substance Use in Youth and Young Adults in Suburban Cook County 2014 School Nurse Conference Steven M. Seweryn, EdD, MPH April 24, 2014 Learning Objectives To become familiar
Students College Full-Time Among Initiation Use Substance in Variation Monthly National Survey on Drug Use and Health Short Report August 27, 2015 MONTHLY VARIATION IN SUBSTANCE USE INITIATION AMONG FULL-TIME
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
CHAPTER 2: Substance Use, Mental Disorders, and Access to Treatment Services in Household Surveys, 2002 2005 2.1 Introduction Drug misuse and abuse, and mental health disorders are major health and social
Substance Abuse Prevention and Treatment Agency March, 2012 1 The mission of the Substance Abuse Prevention and Treatment Agency (SAPTA) is to reduce the impact of substance abuse in Nevada. SAPTA funds
Understanding Pharmacology and Physiology Knowledge of Pharmacology and Physiology is Crucial SAMHSA s Counselor Competencies What is Addiction? NIDA: Why Do People Use Drugs? From Abuse to Addiction Desired
Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health Results from the 2014 National Survey on Drug Use and Health September 2015 ii Behavioral Health
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
Macomb County Office of Substance Abuse MCOSA Executive Summary This report marks the second data profile of alcohol and illicit drugs burden in Macomb County. The first report produced in 2007 detailed
Prescription Drug Abuse in the Workplace Illicit drugs and misuse of alcohol are not the only substances that can affect health and safety in workplaces. Prescription drugs, when used without a prescription
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
. City.Country. Official responsible for providing this information (mandatory) a. Name b. Position Official title c. Institution Name of the institution where you work d. Address Complete postal address
Crosswalk Management System Report Filename Run by REPORT CROSSWALK TO STATE adobe pdf OPS$PCUMMING Report Date 04-MAR-13 01:34 OPS$PCUMMING Page 2 of 32 Status : FN Media ID : CalOMS - CA Start Date :
What are the current costs and outcomes related to mental health and substance abuse disorders? Eighteen percent of adults in the United States have a mental, behavioral, or emotional disorder 12 month
Disclaimer: The views of the author do not necessarily reflect the views and beliefs of the Illinois Higher Education Center, Eastern Illinois University, and The Department of Human Services. Prescription
Prescription Drug Abuse Robert L. Hill Executive Assistant Office of Diversion Control Robert.L.Hill@usdoj.gov (202) 307-4976 Prescription Drug Abuse is the use of a prescription medication, controlled
Prescription Drug Abuse: Recognition, Intervention, and Prevention Nicholas Reuter Division of Pharmacologic Therapy Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration
Understanding the Disease of Addiction & the Process of Recovery for Healthcare Clinicians and Staff Presented by John G. Gardin II, Ph.D., A.C.S. Chief Clinical Officer, ADAPT, Inc./SouthRiver CHC Basic
Treatment Episode Data Set (TEDS) 2002-2012 National Admissions to Substance Abuse Treatment Services DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Acknowledgments
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...
Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt? Medicaid Evidence-Based Decisions Project June 25, 2014 Supported by National Institute
SUBSTANCE ABUSE Substance abuse is a severe issue challenging our county residents' current and future health and well being. In 2010, Washtenaw County Public Health and Washtenaw Community Health Organization
Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for
American Dental Association Providers Clinical Support System on Opioid Therapies Webinar Friday, May 23, 2014 2:00 PM (CDT) Funding for this initiative was made possible (in part) by Providers' Clinical
Substance Use Disorder Services to be a Benefit of Texas Medicaid Information Posted on August 13, 2010 Effective for dates of service on or after September 1, 2010, the following substance use disorder
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,